Opportunity

Saskatchewan Tenders #SSO-CL-0140

Procurement of Integrated Structural Heart TEER Platform for Mitral and Tricuspid Valve Regurgitation

Posted

September 04, 2026

Respond By

September 18, 2026

Identifier

SSO-CL-0140

NAICS

339112, 423450

Health Shared Services Saskatchewan (3sHealth) is seeking to procure an integrated Structural Heart Transcatheter Edge-to-Edge Repair (TEER) platform for mitral and tricuspid valve regurgitation treatment. - Government Buyer: - Health Shared Services Saskatchewan (3sHealth), Provincial Contracting - OEM Highlight: - Abbott Medical Canada Company is the proposed supplier - Abbott's TriClip Transcatheter Edge-to-Edge Repair System is specifically referenced as the only Health Canada licensed TEER device for tricuspid valve regurgitation - Products and Solutions Requested: - Integrated TEER device platform - Implantable TEER devices - Delivery systems - Steerable guide catheters - Procedural accessories - All components must be compatible and Health Canada licensed for both mitral and tricuspid valve indications - Services Requested: - Manufacturer-provided clinical case support and procedural consultation - Physician, nursing, and allied health education and training - Ongoing technical, clinical, and product support - Unique Requirements: - Platform must support both mitral and tricuspid valve regurgitation within a single integrated ecosystem - Provincial standardization and sustainable program delivery are required - Only Health Canada licensed solutions for both indications are acceptable - Other suppliers may submit a Statement of Capabilities if they can meet all requirements

Description

Health Shared Services Saskatchewan (3sHealth) intends to award a contract for an integrated Structural Heart Transcatheter Edge-to-Edge Repair (TEER) platform to support treatment of both mitral and tricuspid valve regurgitation. The contract includes supply of implantable devices, delivery systems, procedural accessories, clinical case support, and training programs. The proposed supplier is Abbott Medical Canada Company, and other suppliers may submit a Statement of Capabilities during the posting period. The contract term is three years with options to extend for two additional one-year periods.

View original listing